These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38580170)

  • 21. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma.
    Gilchuk P; Guthals A; Bonissone SR; Shaw JB; Ilinykh PA; Huang K; Bombardi RG; Liang J; Grinyo A; Davidson E; Chen EC; Gunn BM; Alter G; Saphire EO; Doranz BJ; Bukreyev A; Zeitlin L; Castellana N; Crowe JE
    Front Immunol; 2021; 12():706757. PubMed ID: 34335620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
    Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
    J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus.
    Gunn BM; Yu WH; Karim MM; Brannan JM; Herbert AS; Wec AZ; Halfmann PJ; Fusco ML; Schendel SL; Gangavarapu K; Krause T; Qiu X; He S; Das J; Suscovich TJ; Lai J; Chandran K; Zeitlin L; Crowe JE; Lauffenburger D; Kawaoka Y; Kobinger GP; Andersen KG; Dye JM; Saphire EO; Alter G
    Cell Host Microbe; 2018 Aug; 24(2):221-233.e5. PubMed ID: 30092199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-mAb cocktail protects macaques against the Makona variant of Ebola virus.
    Qiu X; Audet J; Lv M; He S; Wong G; Wei H; Luo L; Fernando L; Kroeker A; Fausther Bovendo H; Bello A; Li F; Ye P; Jacobs M; Ippolito G; Saphire EO; Bi S; Shen B; Gao GF; Zeitlin L; Feng J; Zhang B; Kobinger GP
    Sci Transl Med; 2016 Mar; 8(329):329ra33. PubMed ID: 26962157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease.
    Wang H; Wong G; Zhu W; He S; Zhao Y; Yan F; Rahim MN; Bi Y; Zhang Z; Cheng K; Jin H; Cao Z; Zheng X; Gai W; Bai J; Chen W; Zou Y; Gao Y; Gao GF; Yang S; Xia X; Qiu X
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors.
    Fan P; Chi X; Liu G; Zhang G; Chen Z; Liu Y; Fang T; Li J; Banadyga L; He S; Yu C; Qiu X; Chen W
    MAbs; 2020; 12(1):1742457. PubMed ID: 32213108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop.
    Mire CE; Geisbert TW
    Trends Mol Med; 2017 Aug; 23(8):669-671. PubMed ID: 28697885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emergence of antibody therapies for Ebola.
    Hiatt A; Pauly M; Whaley K; Qiu X; Kobinger G; Zeitlin L
    Hum Antibodies; 2015 Dec; 23(3-4):49-56. PubMed ID: 27472862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection.
    Davis CW; Jackson KJL; McElroy AK; Halfmann P; Huang J; Chennareddy C; Piper AE; Leung Y; Albariño CG; Crozier I; Ellebedy AH; Sidney J; Sette A; Yu T; Nielsen SCA; Goff AJ; Spiropoulou CF; Saphire EO; Cavet G; Kawaoka Y; Mehta AK; Glass PJ; Boyd SD; Ahmed R
    Cell; 2019 May; 177(6):1566-1582.e17. PubMed ID: 31104840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus.
    Howell KA; Brannan JM; Bryan C; McNeal A; Davidson E; Turner HL; Vu H; Shulenin S; He S; Kuehne A; Herbert AS; Qiu X; Doranz BJ; Holtsberg FW; Ward AB; Dye JM; Aman MJ
    Cell Rep; 2017 Apr; 19(2):413-424. PubMed ID: 28402862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do therapeutic antibodies hold the key to an effective treatment for Ebola hemorrhagic fever?
    Takada A
    Immunotherapy; 2013 May; 5(5):441-3. PubMed ID: 23638738
    [No Abstract]   [Full Text] [Related]  

  • 33. Progression of Ebola Therapeutics During the 2014-2015 Outbreak.
    Mendoza EJ; Qiu X; Kobinger GP
    Trends Mol Med; 2016 Feb; 22(2):164-173. PubMed ID: 26774636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Will There Be a Cure for Ebola?
    Cardile AP; Warren TK; Martins KA; Reisler RB; Bavari S
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():329-348. PubMed ID: 27959624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.
    Bornholdt ZA; Herbert AS; Mire CE; He S; Cross RW; Wec AZ; Abelson DM; Geisbert JB; James RM; Rahim MN; Zhu W; Borisevich V; Banadyga L; Gunn BM; Agans KN; Wirchnianski AS; Goodwin E; Tierney K; Shestowsky WS; Bohorov O; Bohorova N; Velasco J; Ailor E; Kim D; Pauly MH; Whaley KJ; Alter G; Walker LM; Chandran K; Zeitlin L; Qiu X; Geisbert TW; Dye JM
    Cell Host Microbe; 2019 Jan; 25(1):49-58.e5. PubMed ID: 30629918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region.
    Flyak AI; Kuzmina N; Murin CD; Bryan C; Davidson E; Gilchuk P; Gulka CP; Ilinykh PA; Shen X; Huang K; Ramanathan P; Turner H; Fusco ML; Lampley R; Kose N; King H; Sapparapu G; Doranz BJ; Ksiazek TG; Wright DW; Saphire EO; Ward AB; Bukreyev A; Crowe JE
    Nat Microbiol; 2018 Jun; 3(6):670-677. PubMed ID: 29736037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and characterization of two GP-specific monoclonal antibodies, which synergistically protect non-human primates against Ebola lethal infection.
    Shcheblyakov D; Esmagambetov I; Simakin P; Kostina L; Kozlov A; Tsibezov V; Grebennikova T; Chifanov D; Rumyantseva I; Boyarskaya N; Sizikova T; Shagarova N; Andrus А; Shatohina I; Syromyatnikova S; Kovalchuk A; Pantyukhov V; Borisevich S; Zubkova O; Tukhvatulin A; Logunov D; Naroditsky B; Gintsburg A
    Antiviral Res; 2019 Dec; 172():104617. PubMed ID: 31593751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.
    Corti D; Misasi J; Mulangu S; Stanley DA; Kanekiyo M; Wollen S; Ploquin A; Doria-Rose NA; Staupe RP; Bailey M; Shi W; Choe M; Marcus H; Thompson EA; Cagigi A; Silacci C; Fernandez-Rodriguez B; Perez L; Sallusto F; Vanzetta F; Agatic G; Cameroni E; Kisalu N; Gordon I; Ledgerwood JE; Mascola JR; Graham BS; Muyembe-Tamfun JJ; Trefry JC; Lanzavecchia A; Sullivan NJ
    Science; 2016 Mar; 351(6279):1339-42. PubMed ID: 26917593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral therapeutics for the treatment of Ebola virus infection.
    Cardile AP; Downey LG; Wiseman PD; Warren TK; Bavari S
    Curr Opin Pharmacol; 2016 Oct; 30():138-143. PubMed ID: 27639220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feverish Quest for Ebola Immunotherapy: Straight or Cocktail?
    Saphire EO; Aman MJ
    Trends Microbiol; 2016 Sep; 24(9):684-686. PubMed ID: 27338027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.